Most Active Stories
- Former UNH Student Goes It Alone In Criminal Court, Wins 'Not Guilty' Verdict
- Update: N.H. AG Says Murder-Suicide Likely In Deaths Of Bedford Mother, Two Children
- Report: Former Chief Justice Banned From UNH Law's Rudman Center
- Why Human Feeding Can Hurt Deer
- Northern Pass Gives $3 Million To Conservation Projects
Wed April 23, 2014
New Painkiller Zohydro Stokes Concerns In N.H.
The FDA has approved this drug, but across New England there’s worry that the drug will only add fuel to the fire of the region’s opiate addiction problem. Lawmakers, governors, health care leaders, are all weighing in with different ideas about how to avoid abuse and yet still help those patients in pain.
- Dr. Gil Fanciullo – professor of anesthesiology at Dartmouth Medical School and director of pain management at Dartmouth-Hitchcock Medical Center, which has said its physicians will not prescribe Zohydro
- Peggy Gilmour – Democratic Senator from Hollis. She has a background in nursing and hospice care, and has served on the Health, Education, and Human Services Committee.
- Dr. Joshua Greenspan – founder of American Pain Institute in Portsmouth. He’s Board Certified in the Specialty of Pain Management.
- James Vara - Assistant Attorney General and head the Drug Prosecution Unit
All Things Considered